TEVA - BNP Paribas Primary New Issues: NO STAB Notice

Date: 27/11/19

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Teva Pharmaceutical Finance Netherlands II

                               B.V.

Post-stabilisation Period Announcement

NO STABILISATION CARRIED OUT

Further to the pre-stabilisation period announcement dated 19/11/19 BNP Paribas, contact: Rupert Lewis telephone: 020 7595 8222 hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014) or the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

You May Also Be Interested In

• Montville’s Troop 74 Rocketeers Selected for NASA Student Launch
• Empowering "Mom, and More": Momcozy is Supplying the Best Solutions This Prime Day
• Luvme Originalive™ Takes a Slower Approach to Premium Wig Color